Àü¸³¼±¾Ï Áø´Ü ½ÃÀå ±Ô¸ð, Á¡À¯À² ¹× µ¿Ç⠺м® º¸°í¼­ : °Ë»ç À¯Çüº°, À¯Çüº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2030³â)
Prostate Cancer Diagnostics Market Size, Share & Trends Analysis Report By Test Type (Preliminary Tests, Confirmatory Tests), By Type (Adenocarcinoma, Interstitial Cell Carcinoma, Other), By End Use, By Region, And Segment Forecasts, 2024 - 2030
»óǰÄÚµå : 1405892
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2023³â 12¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 152 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,609,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 10,055,000
Printable PDF (5-User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,949,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Àü¸³¼±¾Ï Áø´Ü ½ÃÀå ¼ºÀå ¹× µ¿Çâ :

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¼¼°è Àü¸³¼±¾Ï Áø´Ü ½ÃÀå ±Ô¸ð´Â 2024-2030³â°£ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 6.4%·Î È®´ëµÇ¾î 2030³â¿¡´Â 131¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¤ºÎ Áö¿ø Á¤Ã¥, Àü ¼¼°è Áúº´ À¯º´·ü Áõ°¡, Àü¸³¼±¾Ï À¯º´·ü Áõ°¡ ¹× È®Áø °Ë»ç ±â¼ú ¹ßÀüÀÌ ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀÔ´Ï´Ù.

È¿°úÀûÀÎ Áø´Ü°ú Ä¡·á¿¡ ÃÊÁ¡À» ¸ÂÃá ¿¬±¸¸¦ °­È­Çϱâ À§ÇÑ À¯¸®ÇÑ Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê Áõ°¡´Â ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, ±¹¸³¾Ï¿¬±¸¼Ò´Â '¾ÆÇÁ¸®Ä«°è ³²¼ºÀÇ Àü¸³¼±¾Ï¿¡ ´ëÇÑ ¿¬±¸: À¯ÀüÇÐ, Á¾¾ç ¸¶Ä¿ ¹× »çȸÀû ½ºÆ®·¹½ºÀÇ ¿ªÇÒ Á¤ÀÇ'(RESPOND)¶ó´Â Á¦¸ñÀÇ ¿¬±¸¸¦ ½ÃÀÛÇß½À´Ï´Ù. ÀÌ ¿¬±¸´Â ¾ÆÇÁ¸®Ä«°è ¹Ì±¹ÀÎ ³²¼ºÀÇ Àü¸³¼±¾Ï°ú °ü·ÃµÈ ºñ»ý¹°ÇÐÀû ¹× »ý¹°ÇÐÀû ¿äÀÎÀ» Á¶»çÇÏ´Â ÃÖ´ë ±Ô¸ðÀÇ °øµ¿ ¿¬±¸ÀÔ´Ï´Ù. ¹Ì±¹ ±¹¸³¼Ò¼ö¹ÎÁ·°Ç°­¿¬±¸¼Ò(National Institute on Minority Health and NCI and Health Disparities)°¡ Àü¸³¼±¾ÏÀç´Ü(Prostate Cancer Foundation)°ú °øµ¿À¸·Î ¹ÌÈ­ 2,600¸¸ ´Þ·¯ÀÇ ÀÚ±ÝÀ» Áö¿ø¹Þ¾Æ ½ÃÀÛ ½ÃÀÛÇß½À´Ï´Ù.

³ëÆÜ ´ëÇаú À̽ºÆ® ¾Þ±Û¸®¾Æ ¿¬±¸ °³¹ß ¹× ³ë¸®Ä¡ ´ëÇÐ º´¿øÀº Áø´Ü ÈÄ 5³â À̳»¿¡ Ä¡·á ÀýÂ÷°¡ ÇÊ¿äÇÒ °¡´É¼ºÀÌ ÃÖ´ë 8¹è ³·Àº ³²¼ºÀ» ½Äº°ÇÏ´Â µ¥ µµ¿òÀÌ µÇ´Â ºñħ½ÀÀû ¼Òº¯ °Ë»ç¸¦ °³¹ßÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú ¹ßÀüÀº °¡±î¿î ¹Ì·¡¿¡ ½ÃÀå ÀáÀç·Â¿¡µµ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¶ÇÇÑ, Ä«·Ñ¸°½ºÄ« ¿¬±¸¼Ò¿Í KTH ¿¬±¸¼ÒÀÇ ¿¬±¸ÁøÀº °ø°£ Àü»çüÇп¡ ÀΰøÁö´ÉÀ» Ȱ¿ëÇϸé Àü¸³¼±¾ÏÀ» Á¶±â¿¡ ¹ß°ßÇÒ ¼ö ÀÖ°í, À̸¦ ÅëÇØ ÀÓ»ó Áø´Ü°ú Ä¡·á¸¦ °³¼±ÇÒ ¼ö ÀÖ´Ù´Â °á·ÐÀ» ³»·È½À´Ï´Ù. °ø°£ Àü»çüÇÐÀº ÀϹÝÀûÀ¸·Î Ȱ¼º À¯ÀüÀÚ¿Í ±× Á¶Á÷»óÀÇ Á¤·®Àû ºÐ¼®À» °áÇÕÇÏ¿© È¿°úÀûÀÎ Áúº´ Áø´Ü¿¡ µµ¿òÀÌ µÇ´Â ¹æ¹ýÀÔ´Ï´Ù.

Àü¸³¼±¾Ï Áø´Ü ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Àü¸³¼±¾Ï Áø´Ü ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå Àü¸³¼±¾Ï Áø´Ü ½ÃÀå : °Ë»ç À¯Çü ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦5Àå Àü¸³¼±¾Ï Áø´Ü ½ÃÀå : À¯Çü ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦6Àå Àü¸³¼±¾Ï Áø´Ü ½ÃÀå : ÃÖÁ¾ ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦7Àå Àü¸³¼±¾Ï Áø´Ü ½ÃÀå : Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦8Àå °æÀï ±¸µµ

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Prostate Cancer Diagnostics Market Growth & Trends:

The global prostate cancer diagnostics market size is expected to reach USD 13.16 billion by 2030, expanding at a CAGR of 6.4% from 2024 to 2030,according to a new report by Grand View Research, Inc. Supportive government initiatives, increasing disease prevalence across the globe, and a rise in the prevalence of prostate cancer coupled with technological advancements in confirmatory diagnostic tests are the major drivers for this market.

A rise in favorable government initiatives to enhance research associated with a focus on effective diagnosis and treatment is expected to boost market growth during the forecast period. For instance, the National Cancer Institute initiated the study titled 'Research on Prostate Cancer in Men of African Ancestry: Defining the Roles of Genetics, Tumor Markers, and Social Stress' (RESPOND). This study is the largest collaboration to research the non-biological and biological factors that are associated with prostate cancer in African-American men. It was launched by the National Institute on Minority Health and NCI and Health Disparities in collaboration with the Prostate Cancer Foundation with a funding of USD 26.0 million.

Researchers from the University of Norfolk and East Anglia along with Norwich University Hospital developed a non-invasive urine test that helps in identifying men that are up to 8 times less likely to need a treatment procedure within 5 years of diagnosis. Technological advancements such as these are also anticipated to impact market potential in the near future.

Additionally, researchers at Karolinska and KTH Institute concluded that the use of artificial intelligence in spatial transcriptomics can aid in the early detection of prostate cancer, thereby, improving clinical diagnosis and treatment. Spatial transcriptomics is a method that usually combines quantitative analysis of active genes and their histology and can aid in effective disease diagnosis.

Prostate Cancer Diagnostics Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Prostate Cancer Diagnostics Market Variables, Trends & Scope

Chapter 4. Prostate Cancer Diagnostics Market: Test Type Estimates & Trend Analysis

Chapter 5. Prostate Cancer Diagnostics Market: Type Estimates & Trend Analysis

Chapter 6. Prostate Cancer Diagnostics Market: End Use Estimates & Trend Analysis

Chapter 7. Prostate Cancer Diagnostics Market: Regional Estimates & Trend Analysis

Chapter 8. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â